HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,460 | +5.9% | 300 | 0.0% | 0.00% | – |
| Q2 2023 | $10,821 | -5.6% | 300 | 0.0% | 0.00% | – |
| Q1 2023 | $11,457 | -84.5% | 300 | -76.9% | 0.00% | -100.0% |
| Q4 2022 | $73,970 | +45.0% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $51,000 | -10.5% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $57,000 | +307.1% | 1,300 | +271.4% | 0.00% | – |
| Q3 2021 | $14,000 | -12.5% | 350 | 0.0% | 0.00% | – |
| Q2 2021 | $16,000 | -100.0% | 350 | -79.4% | 0.00% | -100.0% |
| Q1 2021 | $70,874,000 | +472393.3% | 1,700 | +385.7% | 0.00% | – |
| Q4 2020 | $15,000 | -64.3% | 350 | -85.4% | 0.00% | -100.0% |
| Q4 2019 | $42,000 | +13.5% | 2,400 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $37,000 | -24.5% | 2,400 | -16.5% | 0.00% | -50.0% |
| Q2 2019 | $49,000 | -14.0% | 2,875 | -8.1% | 0.00% | -33.3% |
| Q3 2018 | $57,000 | +7.5% | 3,130 | -0.3% | 0.00% | 0.0% |
| Q2 2018 | $53,000 | – | 3,140 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,816,162 | $191,226,000 | 8.73% |
| BB BIOTECH AG | 6,825,532 | $65,866,000 | 2.13% |
| Lombard Odier Asset Management (USA) Corp | 2,700,000 | $26,055,000 | 1.79% |
| SECTORAL ASSET MANAGEMENT INC | 3,724,351 | $35,940,000 | 1.61% |
| QVT Financial LP | 2,010,186 | $19,398,000 | 0.97% |
| JHL Capital Group LLC | 1,475,000 | $14,234,000 | 0.94% |
| MAZAMA CAPITAL MANAGEMENT INC | 358,087 | $3,456,000 | 0.79% |
| EcoR1 Capital, LLC | 160,700 | $1,551,000 | 0.78% |
| Alden Global Capital Ltd | 332,500 | $3,209,000 | 0.77% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,274,065 | $70,195,000 | 0.65% |